A study to evaluate the efficacy and safety of THROZEN (Cough Drop Formulation) for the treatment of cough and sore throat.
- Conditions
- Health Condition 1: J96-J99- Other diseases of the respiratory system
- Registration Number
- CTRI/2018/08/015547
- Lead Sponsor
- MKTS Global Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Human volunteers with cough and/or sore throat issues should be included
Patient with sign and symptoms of viral or bacterial throat infection
Patients between the age above 18 to 65 years from both sex
Patients willing to sign an informed written consent and comply with visit schedules
Patients must be able to communicate effectively with study personnel
Known positive status and known history for HIV, active hepatitis B or hepatitis C.
Pregnant or breast feeding women
Volunteers should not have any disease. Especially respiratory tract disorder and tuberculosis volunteers even with past historyshould not be included
Subjects on any other experimental treatment within 07 days of the first dose of study drug or who have not recovered from the side effects of such therapy
Patient have history of hospitalized treatment before 07 days
Patient taking any other then investigational drug in last 07 days
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method